BE834895A - PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TROPHIC CONNECTIVE TISSUE DISORDERS - Google Patents
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TROPHIC CONNECTIVE TISSUE DISORDERSInfo
- Publication number
- BE834895A BE834895A BE161272A BE161272A BE834895A BE 834895 A BE834895 A BE 834895A BE 161272 A BE161272 A BE 161272A BE 161272 A BE161272 A BE 161272A BE 834895 A BE834895 A BE 834895A
- Authority
- BE
- Belgium
- Prior art keywords
- trophic
- treatment
- pharmaceutical compositions
- connective tissue
- tissue disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19742451212 DE2451212A1 (en) | 1974-10-29 | 1974-10-29 | AGENTS FOR TREATMENT OF TROPHICAL CONNECTIVE TISSUE CHANGES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE834895A true BE834895A (en) | 1976-04-27 |
Family
ID=5929402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE161272A BE834895A (en) | 1974-10-29 | 1975-10-27 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TROPHIC CONNECTIVE TISSUE DISORDERS |
Country Status (5)
| Country | Link |
|---|---|
| BE (1) | BE834895A (en) |
| DE (1) | DE2451212A1 (en) |
| FR (1) | FR2299036A1 (en) |
| GB (1) | GB1472148A (en) |
| NL (1) | NL7512464A (en) |
-
1974
- 1974-10-29 DE DE19742451212 patent/DE2451212A1/en active Pending
-
1975
- 1975-10-23 GB GB4358375A patent/GB1472148A/en not_active Expired
- 1975-10-24 NL NL7512464A patent/NL7512464A/en not_active Application Discontinuation
- 1975-10-27 BE BE161272A patent/BE834895A/en unknown
- 1975-10-28 FR FR7532868A patent/FR2299036A1/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| FR2299036B1 (en) | 1979-03-23 |
| DE2451212A1 (en) | 1976-05-06 |
| GB1472148A (en) | 1977-05-04 |
| NL7512464A (en) | 1976-05-04 |
| FR2299036A1 (en) | 1976-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2316954A1 (en) | DENTAL PREPARATION FOR THE TREATMENT OF PERIODONTOSIS | |
| FR2333515A1 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CALCIUM METABOLISM DISORDERS | |
| BE865156A (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DEPRESSIONS | |
| BE793792A (en) | COMPOSITIONS FOR THE TREATMENT OF THE SKIN | |
| BE829859A (en) | PHARMACEUTICAL METHODS AND COMPOSITIONS FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA | |
| BE799141A (en) | PHARMACEUTICAL COMPOSITION THAT CAN BE USED FOR THE TREATMENT OF OBESITY | |
| BE885291A (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CARDIAC DYSFUNCTION | |
| FR2310769A1 (en) | MEDICINAL PRODUCT FOR THE TREATMENT OF ALOPECIA SEBORRHOEICA | |
| BE856740A (en) | NEW DRUG COMPOSITION FOR THE TREATMENT OF BILIARY LITHIASIS | |
| BE834895A (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TROPHIC CONNECTIVE TISSUE DISORDERS | |
| BE809832A (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SKIN DISEASES | |
| BE814735A (en) | NEW PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HEART DISEASE | |
| BE854412A (en) | PHARMACEUTICAL COMPOSITIONS FOR GYNECOLOGICAL TREATMENT | |
| FR2296415A1 (en) | PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CIRCULATION DISORDERS | |
| BE815825A (en) | COMPOSITION FOR THE TREATMENT OF THE SKIN | |
| BE829024A (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HYDROPISIS | |
| FR2310770A1 (en) | MEDICINAL PRODUCT FOR THE TREATMENT OF ALOPECIA AREATA | |
| BE812974A (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ULCERS | |
| BE815397A (en) | SUGGESTED FOR THE TREATMENT OF CALCIUM TUMORS | |
| BE786326A (en) | NEW PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISORDERS OF INTESTINAL SECRETION | |
| BE805055A (en) | THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF PSYCHOSOMATIC DISORDERS, PSYCHONEVROSIS AND CERTAIN FORMS OF SCHIZOPHRENIA, AND ALSO USED AS AN ANTIEMETIC | |
| BE809833A (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PROLIFERANT SKIN DISEASES | |
| BE791253A (en) | NEW PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF HYPERTONIA | |
| BE848908A (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CALCIUM METABOLISM DISORDERS, | |
| BE834047A (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF THE RESPIRATORY TRACT |